Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
Saved in:
| Title: | Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. |
|---|---|
| Authors: | Belouin SJ; United States Public Health Service, Germantown, MD, USA; Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD, USA; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA. Electronic address: sjbelouin@gmail.com., Averill LA; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, Michael E. DeBakey Veterans Administration Medical Center, Houston, TX, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neurosciences Division, Orange, CT, USA; Reason for Hope, New York, NY, USA., Henningfield JE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Research, Health Policy and Abuse Liability, Pinney Associates, Bethesda, MD, USA., Xenakis SN; Reason for Hope, New York, NY, USA; United States Army, Hallandale Beach, FL, USA; Uniformed Services University of the Health Sciences (UHSUS), Bethesda, MD, USA., Donato I; Office of Prevention Innovation, Center for Substance Abuse Prevention, SAMHSA, Rockville, MD, USA., Grob CS; David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, USA; Division of Child and Adolescent Psychiatry, Harbor-UCLA Medical Center, Torrance, CA, USA., Berger A; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA., Magar V; Gender, Equity and Human Rights, World Health Organization (WHO), Geneva, Switzerland., Danforth AL; The Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA, USA., Anderson BT; University of California San Francisco (UCSF) Department of Psychiatry & Behavioral Sciences, San Francisco, CA, USA; University of California Berkeley Center for the Science of Psychedelics, Berkeley, CA, USA. |
| Source: | Neuropharmacology [Neuropharmacology] 2022 Nov 15; Vol. 219, pp. 109214. Date of Electronic Publication: 2022 Aug 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
